Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies. (Q51101783)
Jump to navigation
Jump to search
scientific article published on 8 March 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies. |
scientific article published on 8 March 2017 |
Statements
Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies (English)
M Del Rio
C Mollevi
F Bibeau
N Vie
J Selves
J-F Emile
C Gongora